Bile acids and incretins as modulators of obesity-associated atherosclerosis
Obesity is one of the major global health concerns of the 21st century, associated with many comorbidities such as type 2 diabetes mellitus (T2DM), metabolic dysfunction-associated steatotic liver disease, and early and aggressive atherosclerotic cardiovascular disease, which is the leading cause of...
Saved in:
Main Authors: | Andrijana Kirsch, Juergen Gindlhuber, Diana Zabini, Elena Osto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1510148/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
by: Mei Dong, et al.
Published: (2025-01-01) -
Role of hyperhomocysteinemia in atherosclerosis: from bench to bedside
by: Wende Tian, et al.
Published: (2025-12-01) -
Lipoprotein (a) levels in children with heterozygous familial hypercholesterolemia
by: Liliya F. Galimova, et al.
Published: (2024-12-01) -
Exploration of the shared diagnostic genes and molecular mechanism between obesity and atherosclerosis via bioinformatic analysis
by: Wenrong An, et al.
Published: (2025-01-01) -
Cellular aspects of immunity involved in the development of atherosclerosis
by: Khalil Khalaf, et al.
Published: (2025-01-01)